[google-translator]

TOTAL GALACTOSE

Disorder: Metabolic

Condition: Classic Galactosemia (types I, II, and III)

Biomarker: Total Galactose (TGal: Galactose + Galactose-1-phosphate)

The TGal assay is intended for the quantitative determination of Total Galactose (i.e. galactose (Gal) + galactose-1-phosphate (Gal-1-P)) concentration in human whole blood. Measurement of TGal in newborn dried blood spots is used as a primary screen in the diagnosis and treatment of Galactosemia, an inborn error of carbohydrate metabolism.

For more information, visit Galactosemia

Print Friendly, PDF & Email

PRODUCT HIGHLIGHTS

• 28-day prepared reagent stability – Three times the in-use stability of other vendor’s kits
First FDA-cleared high throughput assay – Decades of quality production and technical support
• Colorimetric assay – Rapid visual review plate to correlate results

For In Vitro Diagnostic Use.  This device is intended for use by trained, qualified laboratory personnel.

PRODUCT ORDERING INFORMATION

SPOTCHECK® NEONATAL TOTAL GALACTOSE MICROPLATE REAGENT KIT CONFIGURATIONS

PART NO.DESCRIPTIONCONTENTS
81-2000-20K20 PlateReagents Only
81-2000-60K60 PlateReagents Only
81-2000P0060 PlateReagents, Microplates, Controls

AVAILABLE
ACCESSORIES

PART NO.PRODUCT NAMEDESCRIPTION
80-0900P4KSPOTCHECK® Blood Spot ControlsPositive (Deficient) Controls
80-0901P4KSPOTCHECK® Blood Spot ControlsNegative (Normal) Controls
900-0301P00READ PlateFlat bottom, 96 well microplates, case
900-0314P00MotherplateSingle Filter, 96 well microplates, case
DOWNLOAD OUR BROCHURE